About Us
Our Goal
Our History
Our People
About Our Formula
Patient Case Studies
Patient Case Studies
Testimonials
COVID-19
News and Updates
Regencell Foundation
Regencell Foundation
RGC Superhero Program
Investor Relations
Corporate Governance
Stock Information
CEO Message
SEC Filings
Email Alerts
Investor Contacts
Press Releases
Financial Data
Contact Us
Menu
About Us
Our Goal
Our History
Our People
About Our Formula
Patient Case Studies
Patient Case Studies
Testimonials
COVID-19
News and Updates
Regencell Foundation
Regencell Foundation
RGC Superhero Program
Investor Relations
Corporate Governance
Stock Information
CEO Message
SEC Filings
Email Alerts
Investor Contacts
Press Releases
Financial Data
Contact Us
Financial Data
Annual Report
2024
2023
2022
2021
2024
Form 20-F
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023
Form 20-F
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022
Form 20-F
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021
Form 20-F
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financial Data on Form 10-K
2021 10-K
202010-K
2019 10-K
2018 10-K
